FAKTOR-OPTIONSSCHEIN - STRYKER CORP. Stock

Certificat

DE000SN3KF99

Market Closed - Deutsche Boerse AG 15:50:16 2024-05-31 EDT
25.25 EUR -4.39% Intraday chart for FAKTOR-OPTIONSSCHEIN - STRYKER CORP.
Current month-7.37%
1 month-7.37%
Date Price Change
24-05-31 25.25 -4.39%
24-05-30 26.41 -0.83%
24-05-29 26.63 +5.38%
24-05-28 25.27 +7.81%
24-05-27 23.44 -3.46%

Delayed Quote Deutsche Boerse AG

Last update May 31, 2024 at 03:50 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer Société Générale Société Générale
WKN SN3KF9
ISINDE000SN3KF99
Date issued 2022-06-17
Strike 202.2 $
Maturity Unlimited
Parity 1 : 1
Emission price 10.29
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 43.99
Lowest since issue 7.78
Spread 0.61
Spread %2.26%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
341.1 USD
Average target price
373.1 USD
Spread / Average Target
+9.38%
Consensus